Trishna Pani

Gurgaon, HR, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms.

The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms.

Journal: PLoS biology
Published: March 27, 2024

Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression.

Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 30, 2023

Unique sphingolipid signature identifies luminal and triple-negative breast cancer subtypes.

Unique sphingolipid signature identifies luminal and triple-negative breast cancer subtypes.

Journal: International journal of cancer
Published: October 21, 2022

Prediction of transcript structure and concentration using RNA-Seq data.

Prediction of transcript structure and concentration using RNA-Seq data.

Journal: Briefings in bioinformatics
Published: October 03, 2022

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells.

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells.

Journal: Cancers
Published: July 09, 2022

Hydrogel-mediated topical delivery of steroids can effectively alleviate psoriasis via attenuating the autoimmune responses.

Hydrogel-mediated topical delivery of steroids can effectively alleviate psoriasis via attenuating the autoimmune responses.

Journal: Nanoscale
Published: February 23, 2022

Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells.

Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells.

Journal: Oncoscience
Published: March 31, 2021

Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.

Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.

Journal: Cell death & disease
Published: April 08, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026